Sinclair IS Pharma PLC (SPH.L)

SPH.L on London Stock Exchange

30.50GBp
24 Jul 2014
Price Change (% chg)

-0.50p (-1.61%)
Prev Close
31.00p
Open
30.75p
Day's High
30.75p
Day's Low
30.50p
Volume
401,509
Avg. Vol
1,099,569
52-wk High
34.18p
52-wk Low
23.50p

SPH.L

Chart for SPH.L

About

Sinclair IS Pharma plc is a specialty pharmaceutical company focused on treatments in dermatology, wound care, oncology support and critical care through surface technology and delivery systems. It has presence in five European markets and a marketing partner network across developed and emerging markets. On October 1, 2012, the... (more)

Overall

Beta: 0.86
Market Cap (Mil.): £151.71
Shares Outstanding (Mil.): 497.41
Dividend: --
Yield (%): --

Financials

  SPH.L Industry Sector
P/E (TTM): -- 36.00 36.40
EPS (TTM): -0.03 -- --
ROI: -9.92 19.00 18.27
ROE: -11.82 19.78 19.15
Search Stocks

BRIEF-Sinclair Pharma makes $117 mln buy; proposes placing of 62.5 mln shares

* Acquisition agreement to purchase entire issued share capital of Silhouette for a total cash consideration of around $117million (£70.1 million) plus royalties

15 Apr 2014

Sinclair Pharma reports smaller half-year loss

March 25 - Sinclair IS Pharma, which focusses on dermatology, wound care and skin care, reported a smaller loss for the first half as acquisitions boosted its aesthetics business.

25 Mar 2014

BRIEF-Sinclair IS Pharma H1 revenue rises 6.6 pct

March 25 - Sinclair IS Pharma PLC : * Revenues growth 6.6% to £24.5 million (H1 13: £23.0 million) for the six months ended 31 December 2013 * Adjusted EBITDA* increased to £1.1 million (H1 13: £1.0 million) * Loss before tax reduced to £2.5 million (H1 13: loss of £5.8 million) * CEO says H1 results were marginally behind our expectations but these differences are now reversing * CEO says expect the full year results to be in line with our forecasts and with market expectations.

25 Mar 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Peel Hunt
$23.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks